Feasibility study of Docetaxel plus Bevacizumab in selected patient with previously treated advanced NSCLS(non-squamous).
Not Applicable
- Conditions
- Previously treated advanced NSCLC(non-squamous)
- Registration Number
- JPRN-UMIN000003397
- Lead Sponsor
- Cancer Institute Hospital Japanese Foundation for Cancer Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with Brain metastasis. Patinets with symptomatic congestive heart failure,unstable angina pectoris,cardiac arrhythmias,thorombotic events,a history of gross hemoptysis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method